- Home
- RCEL vs AIRS Comparison
RCEL vs AIRS Comparison
Compare RCEL & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- AIRS
- Stock Information
- Founded
- RCEL 2020
- AIRS 2012
- Country
- RCEL United States
- AIRS United States
- Employees
- RCEL N/A
- AIRS N/A
- Industry
- RCEL Medical/Dental Instruments
- AIRS Medical/Nursing Services
- Sector
- RCEL Health Care
- AIRS Health Care
- Exchange
- RCEL Nasdaq
- AIRS Nasdaq
- Market Cap
- RCEL 308.6M
- AIRS 277.3M
- IPO Year
- RCEL N/A
- AIRS 2021
- Fundamental
- Price
- RCEL $8.73
- AIRS $5.29
- Analyst Decision
- RCEL Buy
- AIRS Hold
- Analyst Count
- RCEL 5
- AIRS 3
- Target Price
- RCEL $18.00
- AIRS $5.00
- AVG Volume (30 Days)
- RCEL 251.2K
- AIRS 286.7K
- Earning Date
- RCEL 02-13-2025
- AIRS 02-25-2025
- Dividend Yield
- RCEL N/A
- AIRS N/A
- EPS Growth
- RCEL N/A
- AIRS N/A
- EPS
- RCEL N/A
- AIRS N/A
- Revenue
- RCEL $60,040,000.00
- AIRS $188,780,000.00
- Revenue This Year
- RCEL $36.71
- AIRS N/A
- Revenue Next Year
- RCEL $54.48
- AIRS $9.18
- P/E Ratio
- RCEL N/A
- AIRS N/A
- Revenue Growth
- RCEL 32.24
- AIRS N/A
- 52 Week Low
- RCEL $7.51
- AIRS $2.92
- 52 Week High
- RCEL $18.93
- AIRS $9.20
- Technical
- Relative Strength Index (RSI)
- RCEL 31.80
- AIRS 44.46
- Support Level
- RCEL $8.53
- AIRS $3.83
- Resistance Level
- RCEL $9.42
- AIRS $5.15
- Average True Range (ATR)
- RCEL 0.65
- AIRS 0.50
- MACD
- RCEL -0.39
- AIRS -0.01
- Stochastic Oscillator
- RCEL 3.89
- AIRS 59.84
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.